Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

5-HT2 receptors.

J E Leysen1

  • 1Johnson & Johnson Pharmaceuticals, Business Development, Scientific Licensing, B-2340 Beerse, Belgium.

Current Drug Targets. CNS and Neurological Disorders
|February 18, 2004
PubMed
Summary
This summary is machine-generated.

This review covers 5-HT(2) receptors, including subtypes 5-HT(2A), 5-HT(2B), and 5-HT(2C). It examines their genes, structure, signaling, localization, and related compounds, discussing limited clinical success of selective drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels.

Journal of neuroscience research·2014
Same author

Agonist-induced desensitization of 5-HT(2) receptors on cultured calf aortic smooth muscle cells.

Neurochemistry international·2009
Same author

Effects of lesions on (3)H-apomorphine and (3)H-spiperone stereospecific binding sites in subcellular fractions of rat striatum.

Neurochemistry international·2009
Same author

Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist.

Bioorganic & medicinal chemistry·2006
Same author

Bilateral control of brain activity by dopamine D1 receptors: evidence from induction patterns of regulator of G protein signaling 2 and c-fos mRNA in D1-challenged hemiparkinsonian rats.

Neuroscience·2005
Same author

Synthesis and biodistribution of [(11)C]R116301, a promising PET ligand for central NK(1) receptors.

Bioorganic & medicinal chemistry·2005

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • 5-HT(2) receptors are G-protein coupled receptors with three subtypes: 5-HT(2A), 5-HT(2B), and 5-HT(2C).
  • These subtypes share molecular, structural, and signaling similarities.
  • 5-HT(2A) and 5-HT(2C) receptors are crucial in the central nervous system (CNS) and targeted by antipsychotic and antidepressant drugs.

Purpose of the Study:

  • To review research on 5-HT(2) receptor subtypes.
  • To explore genes, protein structure, signaling, CNS localization, and compounds related to each subtype.
  • To discuss reasons for limited clinical success of selective 5-HT(2) receptor drugs.

Main Methods:

  • Literature review focusing on 5-HT(2) receptor subtypes.
  • Analysis of research concerning genes, protein structure, and receptor signaling.

Related Experiment Videos

  • Examination of receptor localization, particularly in the CNS.
  • Review of compounds targeting 5-HT(2) receptors.

    • Main Results:

    • 5-HT(2A) and 5-HT(2C) receptors are widely distributed in the CNS, influencing neurological functions.
    • 5-HT(2B) receptors have limited CNS expression but are vital for embryogenesis and peripheral functions.
    • Antagonism of 5-HT(2A) and 5-HT(2C) receptors is a mechanism for certain psychiatric medications.

    Conclusions:

    • Despite shared characteristics, 5-HT(2) receptor subtypes exhibit distinct roles and distributions.
    • Understanding these differences is key to developing effective therapeutics.
    • Limited clinical success of subtype-selective drugs may stem from complex receptor interactions or off-target effects.